CHÉOS experts support BC study on new COVID-19 drug
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read MoreDecember 18, 2020
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
This edition includes cannabis use in women with pelvic pain, the association between HPV vaccination and STIs, and anticoagulation for dialysis patients with atrial fibrillation
Read More
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read More
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More
The 34th edition summarizes some of the latest research from CHÉOS Scientists: gender imbalance in ICU admission, urinary tract infection after gynecologic surgery, and recover from work-related injuries.
Read More
Read about the Scientists and research that appeared in the media this summer.
Read More